Td Asset Management Inc Bausch Health Companies Inc. Transaction History

Td Asset Management Inc

  • $108 Billion
  • Q2 2025

A detailed history of Td Asset Management Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 889,912 shares of BHC stock, worth $5.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
889,912
Previous 847,676 4.98%
Holding current value
$5.62 Million
Previous $5.48 Million 8.06%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025
BUY
$4.32 - $6.66 $182,459 - $281,291
42,236 Added 4.98%
889,912 $5.93 Million
Q1 2025

May 07, 2025
SELL
$6.16 - $7.94 $124,795 - $160,856
-20,259 Reduced 2.33%
847,676 $5.48 Million
Q4 2024

Feb 11, 2025
SELL
$7.34 - $9.78 $1.02 Million - $1.36 Million
-139,425 Reduced 13.84%
867,935 $7 Million
Q3 2024

Nov 01, 2024
SELL
$5.22 - $8.26 $497,314 - $786,938
-95,271 Reduced 8.64%
1,007,360 $8.21 Million
Q2 2024

Aug 02, 2024
SELL
$6.1 - $10.41 $255,522 - $436,064
-41,889 Reduced 3.66%
1,102,631 $7.69 Million
Q1 2024

May 08, 2024
SELL
$7.77 - $10.61 $92,058 - $125,707
-11,848 Reduced 1.02%
1,144,520 $12.1 Million
Q4 2023

Feb 12, 2024
BUY
$6.53 - $8.23 $124,860 - $157,365
19,121 Added 1.68%
1,156,368 $9.27 Million
Q3 2023

Oct 27, 2023
BUY
$7.69 - $9.71 $1.3 Million - $1.65 Million
169,531 Added 17.52%
1,137,247 $9.35 Million
Q2 2023

Aug 09, 2023
BUY
$5.72 - $8.8 $97,886 - $150,594
17,113 Added 1.8%
967,716 $7.74 Million
Q1 2023

May 10, 2023
BUY
$6.28 - $9.85 $237,528 - $372,556
37,823 Added 4.14%
950,603 $7.7 Million
Q4 2022

Feb 06, 2023
BUY
$6.09 - $7.93 $683,779 - $890,372
112,279 Added 14.03%
912,780 $5.73 Million
Q3 2022

Nov 07, 2022
SELL
$4.58 - $9.21 $163,643 - $329,073
-35,730 Reduced 4.27%
800,501 $5.55 Million
Q2 2022

Aug 04, 2022
SELL
$7.06 - $23.63 $394,173 - $1.32 Million
-55,832 Reduced 6.26%
836,231 $6.98 Million
Q1 2022

May 10, 2022
SELL
$21.6 - $27.79 $1.74 Million - $2.24 Million
-80,767 Reduced 8.3%
892,063 $20.4 Million
Q4 2021

Feb 10, 2022
SELL
$23.0 - $29.01 $1.71 Million - $2.15 Million
-74,182 Reduced 7.09%
972,830 $26.9 Million
Q3 2021

Nov 09, 2021
SELL
$25.04 - $30.06 $1.8 Million - $2.16 Million
-71,831 Reduced 6.42%
1,047,012 $29.2 Million
Q2 2021

Aug 11, 2021
SELL
$27.43 - $32.7 $587,303 - $700,139
-21,411 Reduced 1.88%
1,118,843 $32.7 Million
Q1 2021

May 14, 2021
BUY
$21.37 - $34.38 $471,507 - $758,560
22,064 Added 1.97%
1,140,254 $36.2 Million
Q4 2020

Feb 16, 2021
BUY
$15.31 - $21.12 $675,783 - $932,236
44,140 Added 4.11%
1,118,190 $23.2 Million
Q3 2020

Nov 10, 2020
SELL
$14.88 - $20.13 $144,261 - $195,160
-9,695 Reduced 0.89%
1,074,050 $16.6 Million
Q2 2020

Aug 13, 2020
BUY
$13.31 - $20.51 $1.47 Million - $2.27 Million
110,586 Added 11.36%
1,083,745 $19.8 Million
Q1 2020

May 15, 2020
SELL
$12.98 - $30.25 $628,011 - $1.46 Million
-48,383 Reduced 4.74%
973,159 $14.9 Million
Q4 2019

Feb 11, 2020
BUY
$18.89 - $31.89 $743,132 - $1.25 Million
39,340 Added 4.01%
1,021,542 $30.6 Million
Q3 2019

Nov 07, 2019
SELL
$20.88 - $25.66 $703,656 - $864,742
-33,700 Reduced 3.32%
982,202 $21.4 Million
Q2 2019

Aug 01, 2019
SELL
$20.52 - $26.45 $233,928 - $301,530
-11,400 Reduced 1.11%
1,015,902 $25.7 Million
Q1 2019

May 08, 2019
SELL
$20.23 - $26.29 $477,428 - $620,444
-23,600 Reduced 2.25%
1,027,302 $25.4 Million
Q4 2018

Feb 01, 2019
SELL
$17.64 - $28.32 $381,094 - $611,825
-21,604 Reduced 2.01%
1,050,902 $19.4 Million
Q3 2018

Nov 01, 2018
BUY
$20.64 - $25.67 $22.1 Million - $27.5 Million
1,072,506 New
1,072,506 $27.5 Million

Others Institutions Holding BHC

# of Institutions
251
Shares Held
243M
Call Options Held
2.44M
Put Options Held
8.42M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.28B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email